A Study of the Efficacy and Safety of Monotherapy With BCD-264 and Darzalex in Subjects With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT06296121 · UNKNOWN
Trial details
- NCT number
- NCT06296121
- Sponsor
- Biocad
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-21
- Primary completion
- 2025-01-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.